Drugmakers Crucell NV and GlaxoSmithKline PLC said Tuesday they will work together on a new vaccine composed of two drugs they were developing separately.
The companies had worked together to research a Crucell vaccine in preclinical studies, and want to begin testing their combined vaccine on humans. They said the preclinical research shows the drugs may work better together than they do separately.
Crucell said malaria kills about 900,000 people a year, making it one of the deadliest diseases in the world.
http://www.businessweek.com/ap/financialnews/D9ETHTIO0.htm
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment